Adicet Bio, Inc. (0HX7.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 58.37M |
| Enterprise Value | 34.19M |
| P/E Ratio | -0.8 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.82 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.71 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.67 |
| Return On Equity | -0.75 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -6.38M |
| EBITDA | -115.73M |
| Net Income | -116.8M |
| Diluted EPS | -16.95 |
Balance Sheet
| Total Cash | 118.19M |
| Total Cash/Share | 11 |
| Total Debt | 12.85M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 6.71 |
| Book Value Per Share | 11.18 |
Price History
| 52-Week Change | -19.22 |
| 52-Week High | 9.48 |
| 52-Week Low | 1.1 |
| Moving Average 50 Days | 2.63 |
| Moving Average 200 Days | 2.95 |
Statistics
| Average Volume | 6,355 |
| Shares Outstanding | 5.2M |
| % Held by Institutions | 27.17 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | December 30, 2025 |
AD
